Non-alcoholic fatty liver disease is a major cause of chronic liver pathology in humans. Fatty
liver disease involves the accumulation of hepatocellular fat in hepatocytes that can …

Introduction: Hepatic steatosis is the histological observation of numerous lipid inclusions
due to an excess accumulation of triacylglycerols. They are a concern with new therapeutic …

Liver disease is a major health issue characterized by several pathological changes, with
steatosis (fatty liver) representing a common initial step in its pathogenesis. Steatosis is of …

This review showed the common pathogenic mechanism in the development of non-
alcoholic or alcoholic steatohepatitis. In particular, we describe the role of innate immune …

Hepatic steatosis is now understood to play an important role in the development of
advanced liver disease. Alcoholic and nonalcoholic fatty liver each begin with the …

Metabolic-associated fatty liver disease (MAFLD), which is often linked to obesity,
encompasses a large spectrum of hepatic lesions, including simple fatty liver …

Background: Toxicant-associated fatty liver disease (TAFLD) is a recently identified form of
nonalcoholic fatty liver disease (NAFLD) associated with exposure to industrial chemicals …

Nonalcoholic fatty liver disease (NAFLD) is a chronic liver disease that occurs in nondrinkers
but which cannot be distinguished from alcohol-induced liver disease histologically. There …

Toxic liver disease, hepatotoxicity, encompasses numerous different individual diseases that
ultimately lead to progressive damage of the liver, to liver malfunction and death …

Nonalcoholic fatty liver disease is a relatively new hepatic sequela of obesity and type 2
diabetes. The pathogenesis of liver injury and disease progression in nonalcoholic fatty liver …